Polyglutamate Camptothecin in Treating Patients With Advanced Cancer
This study has been completed.
Memorial Sloan Kettering Cancer Center.
Information provided by:
National Cancer Institute (NCI)
First received: May 6, 2003
Last updated: May 29, 2013
Last verified: April 2005
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||May 2005|
|Estimated Primary Completion Date:||No date given|
McNamara MV, Doroshow JH, Dupont J, et al.: Preliminary pharmacokinetics of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies. [Abstract] J Clin Oncol 22 (Suppl 14): A-2073, 145s, 2004.
Springett GM, Takimoto C, McNamara M, et al.: Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies. [Abstract] J Clin Oncol 22 (Suppl 14): A-3127, 226s, 2004.